Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansgar Weltermann

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Thrombosis Research|August 12, 2008
Circulating tissue factor-exposing microparticlesDaniel Lechner, Ansgar Weltermann
Seminars in Thrombosis and Hemostasis|July 23, 2008
Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?Daniel Lechner, Ansgar Weltermann
Wiener Klinische Wochenschrift|July 1, 2006
[Adult autoimmune thrombocytopenia: diagnosis and treatment]Klaus Lechner, Ansgar Weltermann, Ingrid Pabinger
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
Novel anticoagulants for the prevention and treatment of venous thromboembolismAnsgar Weltermann, Paul A Kyrle, Sabine Eichinger
Clinical Pharmacology and Therapeutics|June 24, 2026
Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused RegistriesManon C Wilpshaar, Doranne Hilarius, Luisa Prada, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Mortality in severe, non aggressively treated adult autoimmune thrombocytopeniaThomas Sailer, Ansgar Weltermann, Claudia Zoghlami, et al.
Wiener Klinische Wochenschrift|August 16, 2019
Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular riskMarkus C Stühlinger, Ansgar Weltermann, Philipp Staber, et al.
European Journal of Clinical Investigation|May 12, 2010
Low dose acetylsalicylic acid and shedding of microparticles in vivo in humansBarbara Lubsczyk, Marietta Kollars, Gregor Hron, et al.
The New England Journal of Medicine|June 18, 2004
The risk of recurrent venous thromboembolism in men and womenPaul A Kyrle, Erich Minar, Christine Bialonczyk, et al.
British Journal of Haematology|December 21, 2002
Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?Robert A Bucek, Markus Reiter, Peter Quehenberger, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Thrombosis Research|August 12, 2008
Circulating tissue factor-exposing microparticlesDaniel Lechner, Ansgar Weltermann
Seminars in Thrombosis and Hemostasis|July 23, 2008
Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?Daniel Lechner, Ansgar Weltermann
Wiener Klinische Wochenschrift|July 1, 2006
[Adult autoimmune thrombocytopenia: diagnosis and treatment]Klaus Lechner, Ansgar Weltermann, Ingrid Pabinger
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
Novel anticoagulants for the prevention and treatment of venous thromboembolismAnsgar Weltermann, Paul A Kyrle, Sabine Eichinger
Clinical Pharmacology and Therapeutics|June 24, 2026
Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused RegistriesManon C Wilpshaar, Doranne Hilarius, Luisa Prada, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Mortality in severe, non aggressively treated adult autoimmune thrombocytopeniaThomas Sailer, Ansgar Weltermann, Claudia Zoghlami, et al.
Wiener Klinische Wochenschrift|August 16, 2019
Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular riskMarkus C Stühlinger, Ansgar Weltermann, Philipp Staber, et al.
European Journal of Clinical Investigation|May 12, 2010
Low dose acetylsalicylic acid and shedding of microparticles in vivo in humansBarbara Lubsczyk, Marietta Kollars, Gregor Hron, et al.
The New England Journal of Medicine|June 18, 2004
The risk of recurrent venous thromboembolism in men and womenPaul A Kyrle, Erich Minar, Christine Bialonczyk, et al.
British Journal of Haematology|December 21, 2002
Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?Robert A Bucek, Markus Reiter, Peter Quehenberger, et al.
Pageof 6